Cytogenetic and molecular analysis of early stage renal cell carcinomas in a family with a translocation (2;3)(q35;q21)

被引:14
作者
Bodmer, D
Eleveld, M
Ligtenberg, M
Weterman, M
van der Meijden, A
Koolen, M
Hulsbergen-van der Kaa, C
Smits, A
Smeets, D
van Kessel, AG
机构
[1] Univ Nijmegen, Ctr Med, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands
[2] Univ Nijmegen, Ctr Med, Dept Pathol, NL-6500 HB Nijmegen, Netherlands
[3] Bosch Medicentrum, Dept Urol, NL-5200 ME Den Bosch, Netherlands
[4] Bosch Medicentrum, Dept Nephrol, NL-5200 ME Den Bosch, Netherlands
关键词
D O I
10.1016/S0165-4608(01)00585-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Previously, we described a family With renal cell carcinoma (RCC) and a constitutional balanced t(2;3) (q35;q21). Based on loss of heterozygosity and von Hippel-Lindau (VHL) gene mutation analyses in five tumor biopsies from three patients in this family, we proposed a multistep model for RCC development in which the familial translocation may act as a primary oncogenic event leading to (nondisjunctional) loss of the translocation-derived chromosome 3, and somatic mutation of the VHL gene as a secondary event related to tumor progression. Here, we describe the cytogenetic and molecular analysis of three novel tumors at early stages of development in two members of this family, Again, loss of derivative chromosome 3 was found in two of these tumors and a VHL mutation in one of them. In the third tumor, however, none of these abnormalities could be detected. These result,, underline our previous notion that loss of derivative chromosome 3 and VHL gene mutation play critical roles in familial RCC. In addition, they show that both anomalies may occur at relatively early stages of tumor development, (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:6 / 12
页数:7
相关论文
共 31 条
  • [21] Renal-cell carcinoma
    Motzer, RJ
    Bander, NH
    Nanus, DM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (12) : 865 - 875
  • [22] A TUMOR-SUPPRESSOR LOCUS WITHIN 3P14-P12 MEDIATES RAPID CELL-DEATH OF RENAL-CELL CARCINOMA IN-VIVO
    SANCHEZ, Y
    ELNAGGAR, A
    PATHAK, S
    KILLARY, AM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (08) : 3383 - 3387
  • [23] Schmidt L, 1995, Cancer J Sci Am, V1, P191
  • [24] Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas
    Schmidt, L
    Duh, FM
    Chen, F
    Kishida, T
    Glenn, G
    Choyke, P
    Scherer, SW
    Zhuang, ZP
    Lubensky, I
    Dean, M
    Allikmets, R
    Chidambaram, A
    Bergerheim, UR
    Feltis, JT
    Casadevall, C
    Zamarron, A
    Bernues, M
    Richard, S
    Lips, CJM
    Walther, MM
    Tsui, LC
    Geil, L
    Orcutt, ML
    Stackhouse, T
    Lipan, J
    Slife, L
    Brauch, H
    Decker, J
    Niehans, G
    Hughson, MD
    Moch, H
    Storkel, S
    Lerman, MI
    Linehan, WM
    Zbar, B
    [J]. NATURE GENETICS, 1997, 16 (01) : 68 - 73
  • [25] Familial non-VHL non-papillary clear-cell renal cancer
    Teh, BT
    Giraud, S
    Sari, NF
    Hii, SI
    Bergerat, JP
    Larsson, C
    Limacher, JM
    Nicol, D
    [J]. LANCET, 1997, 349 (9055) : 848 - 849
  • [26] Renal cell cancer: Chromosome 3 translocations as risk
    van Kesel, AG
    Wijnhoven, H
    Bodmer, D
    Eleveld, M
    Kiemeney, L
    Mulders, P
    Weterman, M
    Ligtenberg, M
    Smeets, D
    Smits, A
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (13): : 1159 - 1160
  • [27] vandenBerg A, 1997, GENE CHROMOSOME CANC, V19, P59, DOI 10.1002/(SICI)1098-2264(199706)19:2<59::AID-GCC1>3.3.CO
  • [28] 2-O
  • [29] Cytogenetic classification of renal cell cancer
    vandenBerg, E
    Dijkhuizen, T
    Oosterhuis, JW
    vanKessel, AG
    deJong, B
    Storkel, S
    [J]. CANCER GENETICS AND CYTOGENETICS, 1997, 95 (01) : 103 - 107
  • [30] Zajaczek S, 1999, CYTOGENET CELL GENET, V85, P172